November 18, 20240 Comments

Stock Market Today: Dow edges lower after worst week for S&P 500 in two months

How are stock-index futures trading: Dow Jones Industrial Average futures fell 49 points, or 0.11%, to 43,519 S&P 500 futures increased 11.25 points, or 0.2%, to 5,908 Nasdaq 100 futures increased 143.75 points, or 0.7%, to 20,638 On Friday, the Dow Jones Industrial Average fell 306 points, or 0.7%, to 43,445, the S&P 500 declined 79 points, or 1.32%, to 5,871, and the Nasdaq Composite dropped 428 points, or 2.24%,

Read More
November 18, 20240 Comments

ASR Nederland shares climb as UBS upgrades stock to ‘buy’ By Investing.com

Investing.com — Shares of ASR Nederland (AS:) rose on Monday following an upgrade from UBS, which revised its rating of the stock to “buy” from “neutral.” The brokerage cited several compelling factors, including strong shareholder returns, attractive valuations, and increased potential for further share buybacks.  UBS analysts flagged that ASR’s recent capital actions signal confidence in its financial health and future growth. Earlier this month, ASR announced a surprise €100

Read More
November 15, 20240 Comments

Berkshire bites into Domino’s Pizza, dips into Pool amid stock retreat By Reuters

By Jonathan Stempel (Reuters) -Warren Buffett’s Berkshire Hathaway (NYSE:) said on Thursday it made new investments in Domino’s Pizza (NYSE:) and Pool Corp (NASDAQ:) in the third quarter, even as it retrenched from stocks such as Apple (NASDAQ:) and Bank of America. Berkshire owned 1.28 million Domino’s shares worth about $549 million as of Sept. 30. It also owned 404,000 shares of Pool, a distributor of swimming pool supplies, worth

Read More
November 15, 20240 Comments

Adobe, Amazon lead Friday’s market cap stock movers By Investing.com

Friday’s trading session has seen significant movements among mega-cap and large-cap stocks. Adobe Systems Inc (NASDAQ:) and Amazon.com Inc (NASDAQ:) experienced notable declines, while Palantir Technologies Inc (NYSE:) surged. Here’s a rundown of today’s key stock movers across different market capitalization ranges. Mega-Cap Movers (Market Cap $200B+): Adobe Sys Inc (ADBE): -5.2% Amazon Com Inc (AMZN): -4.75% Eli Lilly And Co (NYSE:): -4.35% Nvidia Corp (NASDAQ:): -4.13% Facebook Inc (NASDAQ:):

Read More
November 14, 20240 Comments

Factors that can make a stock expensive but still a good buy

Breadcrumb Trail Links Investor Peter Hodson: Automatically giving up on a stock because it is expensive does investors a disservice Published Nov 14, 2024  •  Last updated 2 hours ago  •  5 minute read You can save this article by registering for free here. Or sign-in if you have an account. A Nvidia Corp. office building in Santa Clara, Calif. Photo by Jeff Chiu/AP files Article content When talking to investors,

Read More
November 13, 20240 Comments

Amazon, Chevron lead Wednesday’s market cap stock movers By Investing.com

Wednesday’s market has seen notable shifts with stocks like Amazon Com Inc (NASDAQ:) and Chevron (NYSE:) experiencing movement on the upside, while Advanced Micro Devices (NASDAQ:) faced a downturn. Investors are reacting to a mix of earnings reports, strategic announcements, and industry developments. Below are highlights of some of the biggest stock movers, from mega-caps to small caps. Mega-Cap Movers (Market Cap $200B+): Amazon Com Inc (AMZN); Apple (NASDAQ:) To

Read More
November 13, 20240 Comments

Super Micro Computer stock falls after delaying 10-Q filling By Investing.com

Super Micro Computer (NASDAQ:) shares dropped over 4% in premarket trading Wednesday following the company’s announcement of a delay in filing its quarterly 10-Q report for the period ending September 30, 2024. A Form 10-Q is the company’s quarterly financial report. In its press release, Super Micro Computer attributed the delay to unresolved issues related to an ongoing internal review of the company’s controls and reporting processes. The review, initiated

Read More
November 13, 20240 Comments

Amgen stock falls on weight loss drug’s bone density loss data

Shares of Amgen fell more than 7% Tuesday as analysts chewed over bone density loss data from an early-stage trial on its experimental weight loss injection, MariTide. One analyst said the additional data suggests a new potential safety risk tied to the drug. But others said the share move was an overreaction, and that more data on a larger group of patients is needed. Amgen did not immediately respond to

Read More
  • 1
  • 2